RE:Aphria German Sales underway from Neumünster FacilityJust on a side note, if anyone gives a hoot or is just busy praying and needs a break lol
- The 50 kg delivered is the only article I can find in regards to the amount supplied since July
- All articles only state that they have made their first shipment (as we know)
- This is the first full Q since the start of deliveries from Neumnster
- I'm Sure their were many deliveries in EU/Germany, other than CCPharma, which also will be in its full Q from Neumnster.
I'm going to be optimistic here, and say a 4% increase in Distribution Revenues
- Nanaimo slowly shutting down starting in September, 2021...In Q2 (should help a lot with
synergies)
- Manitoba Harvest 2nd full Q
- Sales in Canada are still going to be up, even if we did loose some market share
Really doesn't matter now though...If you're IN, you're IN
Optimistic - counting on decent earnings, increased synergies, lower operating cost, less cash burn from Q1 annnnnnnd Green day tomorrow.
Doesn't matter now though...If you're IN, you're IN
Ready for the verbal beating tomorrow ;-)
glta
V
Ventura2020 wrote: Report from European Cannabis Association may have some impact on Q2, since deliveries only started in July, 2021 and only from 1 out of 3 contracted companies...Aphria! 50kg is not much, but sales to the bottom line. Who knows what they delivered from August through to December.
Like to see a nice surprise out of Germany with an increase in Distribution Revenue, to add to Total Revenue. Of course the analyst will ignore Germany as per usual.
Following a tendering procedure, the Cannabis Agency contracted three companies (Aphria RX GmbH, Aurora Productions GmbH and Demecan GmbH) to cultivate cannabis flowers in a quanity of 10,400 kg over four years with 2,600 kg each year and another company (Cansativa GmbH) to distribute the products on behalf of the Cannabis Agency. The tender included the option of possible additional production. Thus, the contract allows increases in production volumes and delivery of a maximum of 150 percent of the annual plan requirement. It is stated in industry circles that the quantities have already been adjusted upward.
The first deliveries of cannabis flowers from German cultivation were initially scheduled for the end of 2020. Due to the COVID-19 pandemic, as well as other reasons, cultivation was delayed. Thus, it was not until July 2021 that Aphria, so far the only producing company of the three commissioned, delivered cannabis flowers for the first time. Almost 50 kg of cannabis was delivered to pharmacies from the production facility in Neumnster.
As of December 2020, the Cannabis Agency pays cultivating companies an average purchase price of 2.20 EUR per gram whereas the agency’s dispensing price to pharmacies amounts to around 4.30 EUR per gram. The Cannabis Agency itself may not generate any profits. The price only takes into account the personnel and materials costs incurred by BfArM. As of today, it is about half of the usual delivery price to the market.
Should the three companies fullfil the contractually promised harvests one day, this could have a substantial influence on market prices.
https://www.europeancannabisassociation.com/medical-cannabis-made-in-germany/
eom
V